Key result
Protein kinase C plays an integral role in cardiovascular disease pathogenesis and represents a potential therapeutic target for conditions such as ischemic heart disease and heart failure.
Answers are grounded in this paper and cite their sources.
Protein kinase C plays an integral role in cardiovascular disease pathogenesis and represents a potential therapeutic target for conditions like ischemic heart disease, heart failure, and atherosclerosis.
Protein kinase C (PKC) is a member of a large family of serine/threonine kinases that plays an integral role in many of the signaling cascades that govern cellular behavior. As such, it is intricately involved in the processes that mediate disease pathogenesis. Strategies that serve to alter PKC function may prove to be useful in the treatment of numerous disease states. This article reviews the various roles PKC may play in cardiovascular disease, specifically with regard to ischemic heart disease, cardiac hypertrophy, heart failure, hypertension, and atherosclerosis, and suggests the potential for developing therapeutic approaches that can target PKC activity.
No takes yet. Share an insight, caveat, or question.
Murphy et al. (2005) conducted a review in Cardiovascular disease. Protein kinase C (PKC) targeted therapies was evaluated. Protein kinase C plays an integral role in cardiovascular disease pathogenesis and represents a potential therapeutic target for conditions such as ischemic heart disease and heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: